Microencapsulation of bacteriophage felix O1 into chitosan-alginate microspheres for oral delivery. - Wikidata - awgldk - TriplyDB

Microencapsulation of bacteriophage felix O1 into chitosan-alginate microspheres for oral delivery.

Microencapsulation of bacteriophage felix O1 into chitosan-alginate microspheres for oral delivery.

http://www.wikidata.org/entity/Q42121461

about

Bacteriophage Procurement for Therapeutic Purposes Characterization of Five Podoviridae Phages Infecting Citrobacter freundii.The in vivo efficacy of two administration routes of a phage cocktail to reduce numbers of Campylobacter coli and Campylobacter jejuni in chickens.Effect of psyllium and gum Arabic biopolymers on the survival rate and storage stability in yogurt of Enterococcus duransIW3 encapsulated in alginate Evaluation of Anti-SE Bacteriophage as Feed Additives to Prevent Salmonella enteritidis (SE) in Broiler.Genomic, proteomic and physiological characterization of a T5-like bacteriophage for control of Shiga toxin-producing Escherichia coli O157:H7.Phage survival: the biodegradability of M13 phage display library in vitro.Impact of a single phage and a phage cocktail application in broilers on reduction of Campylobacter jejuni and development of resistance Liposome-Encapsulated Bacteriophages for Enhanced Oral Phage Therapy against Salmonella spp Bacteriophages as antimicrobial agents against major pathogens in swine: a review Genetically manipulated phages with improved pH resistance for oral administration in veterinary medicine.Evaluation of the efficacy of chitosan nanoparticles loaded ΦKAZ14 bacteriophage in the biological control of colibacillosis in chickens.Means to Facilitate the Overcoming of Gastric Juice Barrier by a Therapeutic Staphylococcal Bacteriophage A5/80.Bacteriophages against Serratia as Fish Spoilage Control Technology.The factors affecting effectiveness of treatment in phages therapy.Use of encapsulated bacteriophages to enhance farm to fork food safety.A first step toward liposome-mediated intracellular bacteriophage therapy.Genome characterization of a novel vibriophage VpKK5 (Siphoviridae) specific to fish pathogenic strain of Vibrio parahaemolyticus.Ménage à trois in the human gut: interactions between host, bacteria and phages.Recent advances in therapeutic delivery systems of bacteriophage and bacteriophage-encoded endolysins.Microencapsulation with alginate/CaCO3: A strategy for improved phage therapy.Characterization of two polyvalent phages infecting Enterobacteriaceae.Temporal distribution of encapsulated bacteriophages during passage through the chick gastrointestinal tract.Phages in modified alginate beads.Characterization and formulation into solid dosage forms of a novel bacteriophage lytic against Klebsiella oxytoca.Microencapsulation of Clostridium difficile specific bacteriophages using microfluidic glass capillary devices for colon delivery using pH triggered release.Bacteriophages and their role in food safety.Design and characterization of chitosan-alginate microspheres for ocular delivery of azelastine.Incorporation of T4 bacteriophage in electrospun fibres.glnA truncation in Salmonella enterica results in a small colony variant phenotype, attenuated host cell entry, and reduced expression of flagellin and SPI-1 associated effector genes.Protective approaches and mechanisms of microencapsulation to the survival of probiotic bacteria during processing, storage and gastrointestinal digestion: a review.Encapsulation Strategies of Bacteriophage (Felix O1) for Oral Therapeutic Application.Rethinking the bile acid/gut microbiome axis in cancer.Applications for Bacteriophage Therapy during Pregnancy and the Perinatal Period.Nano/Micro Formulations for Bacteriophage Delivery.Encapsulation of Listeria Phage A511 by Alginate to Improve Its Thermal Stability.Oral delivery systems for encapsulated bacteriophages targeted at Escherichia coli O157:H7 in feedlot cattle.A bacteriophage cocktail targeting Escherichia coli reduces E. coli in simulated gut conditions, while preserving a non-targeted representative commensal normal microbiota.Semi-Solid and Solid Dosage Forms for the Delivery of Phage Therapy to Epithelia.Bacteriophage cocktail for biocontrol of Escherichia coli O157:H7: Stability and potential allergenicity study.

P2860

Q26738479-7F503095-BA6A-47CB-B280-914757DA214A Q30008888-C778A685-919A-46A1-BFA9-0E4ABD3A510D Q30988850-D44D6E1F-672E-4C3F-9235-05BFED7A4511 Q33738228-3F9D32C6-48AA-41F3-9850-EECED840D5B5 Q33886221-31BB53AD-AD56-4C96-BE89-BD5372DA1484 Q34238595-A3F0CE02-5442-44FB-9E26-766B46441B52 Q34668868-E74F0856-2C43-417E-97AF-B0DF033B6B4C Q35036500-74133C8F-1295-46CB-8AE0-44B6EC8FCC15 Q35625761-5741C799-14C0-47B7-8364-E9726EE9BC63 Q35994120-13439BC4-77D2-4E80-940E-D2B88D527719 Q37504784-45C84E32-74F2-467C-90C1-4E8E0457A48A Q37606227-144729FD-DE35-4D2D-9D6B-DDB38790330F Q37716726-0843AF02-5AF0-49EE-95E2-1C2FB6C3EA70 Q37736096-67C3F540-03BC-44AF-9F0C-C073EA002C2E Q38193804-EF4EAE96-9AF2-4F82-93D6-FB382B8FC8D8 Q38584325-BC05FE26-73FF-431C-8107-CCF07D68F950 Q38879534-4E00B18E-8F26-4F00-90D3-DA1D454A8781 Q38897409-B16E188F-9B8D-4A4D-8775-D7FDFF7E1DFC Q39276552-127DA624-41C0-4945-BC00-B53A30D447F6 Q39386520-6338DA15-652F-477F-A228-957F7B506C27 Q40358982-5B1A08C7-96D2-453D-9B4B-136A1C3C4923 Q40370546-C71234A5-5406-4629-A016-F0575083C5AA Q40554139-94C1DBF4-B34E-42FB-9AB5-E0ED11DE223A Q40831458-2BEA8497-322F-4343-A70D-0696495CD4D7 Q41443659-0D6AD231-6941-4098-BF8F-D47C3DF71138 Q41918244-81A54479-4C0C-4439-B014-8BC9197976BC Q42029552-0DE6B1C0-F91E-4363-8B28-66DFB3F7D090 Q44187608-B0F5BB41-530B-4C97-982C-ED48C2B00717 Q46468879-A84C065D-6B2F-4F87-B2B3-C77A54280C1B Q47390261-A44CC2B0-8FF6-4949-84F0-FB8568D40F6E Q47652480-6BB49539-D997-4CF9-8303-63B96326110F Q48602182-75C875C2-FA8A-4C1C-BF36-FC8B6727567C Q49216860-1EF902F7-4DCF-4927-9C6E-6A71AB3884F2 Q49631079-EAE368D5-CDDB-44DF-BDEB-C8F8A29AA6BC Q49934113-0EAD2407-73FA-48FB-B731-6B17221E991F Q50036621-CD536291-997F-4ABD-B522-2ACE4D6F14A1 Q51626344-416F41DC-8568-4ED3-8850-BD7DC36E2D2C Q51742889-D72AE51C-9ED5-43A5-A388-B56C204577CC Q55193419-2AF71B95-53B2-4B26-A62E-70082D1F66D5 Q55397634-27D859FD-FA50-4A01-A081-5583B11761EF

P2860

Microencapsulation of bacteriophage felix O1 into chitosan-alginate microspheres for oral delivery.

http://www.wikidata.org/entity/Q42121461

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Microencapsulation of bacterio ...... icrospheres for oral delivery.

@en

Microencapsulation of bacterio ...... icrospheres for oral delivery.

@nl

type

label

Microencapsulation of bacterio ...... icrospheres for oral delivery.

@en

Microencapsulation of bacterio ...... icrospheres for oral delivery.

@nl

prefLabel

Microencapsulation of bacterio ...... icrospheres for oral delivery.

@en

Microencapsulation of bacterio ...... icrospheres for oral delivery.

@nl

P1433

Q42121461-50B05BD9-624D-48CF-8CD8-4FB30423FD34

P1476

Q42121461-CFD06945-2DA5-49D8-B36B-2C2EDED5B2E8

P2093

Q42121461-05F74D6E-E3A7-4588-A13A-5918EC6A2BAA

Q42121461-1BA9E5B5-080C-403E-B7CD-D7997F12708D

Q42121461-1BE6AB50-D791-494D-915B-433B3A6A0DA0

Q42121461-237D6921-66C1-4F71-85C7-ACDB15D0A31B

Q42121461-62592079-48AD-44F3-AAF2-A4E1977F6764

Q42121461-C9FB3BFE-3AC2-4D7C-9100-0F4471AB9AD0

Q42121461-E15F5E5C-48BF-46CA-ADD4-DA15E92BA050

P2860

Q42121461-103BF89C-ACC3-4A86-A63A-65EF5543DA5E

Q42121461-11BE8979-DB6E-4F14-B9EB-6211280B85ED

Q42121461-165C21FC-0E33-44C4-A580-585C99684639

Q42121461-270681A1-9CAF-47AD-9B66-6F245F3A8A1C

Q42121461-2C1D6A4D-6C25-46D7-84F2-79E4DE31A50D

Q42121461-2EE59B9F-7A0C-4A95-BE5D-A1011BC1D17E

Q42121461-3B1B635E-8E56-499F-BB13-2FA87B0F9DA0

Q42121461-3F39FF8E-2626-49C5-9FAD-B09211D576D5

Q42121461-435C3DE8-8FCF-4476-9488-0AD76D83279D

Q42121461-4B6FE479-2AC4-4733-91D0-5E42B562AFD9

P304

Q42121461-BF750F85-996A-41A2-AB23-2532A3E7D8DD

P31

Q42121461-A7C582D3-984E-40E7-B178-709BBD430469

P356

Q42121461-78DDB87D-62E9-427C-9CC4-B7D14B1A20F7

P407

Q42121461-43D9AC38-50C8-4CD3-BA43-5D10E3A30E09

P433

Q42121461-A97577DD-A89C-486A-9C11-2DCC05D1F06B

P478

Q42121461-B37ED86E-C75E-4A11-A3E8-F8AFA26C9A65

P577

Q42121461-9E3C413D-A0DA-4CBE-B0FE-364065B2FD85

P5875

Q42121461-08197521-BF32-4CCA-9D08-3B624F3911A0

P698

Q42121461-0353EEA3-08CE-453E-A18C-83C0EDEE3A81

P921

Q42121461-6D140F8A-C9B2-4040-84C5-8BBC1B26C1A6

Q42121461-E759186E-4782-49C0-805F-AA81E3AA9E20

P932

Q42121461-6429CD3B-A7E2-4FBD-8BDE-9D7690DC2BB0

P356

P1433

Applied and Environmental Microbiology

P1476

Microencapsulation of bacterio ...... icrospheres for oral delivery.

@en

P2093

Anton Korenevsky

http://www.w3.org/2001/XMLSchema#string

Jennifer C Pacan

http://www.w3.org/2001/XMLSchema#string

Parviz M Sabour

http://www.w3.org/2001/XMLSchema#string

Qi Wang

http://www.w3.org/2001/XMLSchema#string

Xiaoqing Huang

http://www.w3.org/2001/XMLSchema#string

Yongping Xu

http://www.w3.org/2001/XMLSchema#string

Yongsheng Ma

http://www.w3.org/2001/XMLSchema#string

P2860

Effect of water-based microencapsulation on protection against EDIM rotavirus challenge in mice.

Bacteriophage therapy

Comparison of several methods for preserving bacteriophages

Technology of mammalian cell encapsulation.

Salmonella enterica serotype Bredeney: antimicrobial susceptibility and molecular diversity of isolates from Ireland and Northern Ireland.

Transit of pharmaceutical dosage forms through the small intestine.

Efficacy and pharmacokinetics of bacteriophage therapy in treatment of subclinical Staphylococcus aureus mastitis in lactating dairy cattle

Alternatives to antibiotics: bacteriocins, antimicrobial peptides and bacteriophages.

In vitro and in vivo bacteriolytic activities of Escherichia coli phages: implications for phage therapy.

Development of oral microencapsulated forms for delivering viral vaccines.

P304

4799-4805

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AEM.00246-08

http://www.w3.org/2001/XMLSchema#string

P407

P433

15

http://www.w3.org/2001/XMLSchema#string

P478

74

http://www.w3.org/2001/XMLSchema#string

P577

2008-05-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5336498

http://www.w3.org/2001/XMLSchema#string

P698

18515488

http://www.w3.org/2001/XMLSchema#string

P921

P932

2519356

http://www.w3.org/2001/XMLSchema#string